Elie Haddad

Elie Haddad

Company: University of Montreal

Job title: Professor of Paediatrics


Dr. E. Haddad specializes in clinical and basic research in pediatric immunology.

In 2005, he was recruited by CHU Sainte-Justine as a physician-scientist and the head of the Immuno-Allergy and Rheumatology Division. Dr Haddad is Professor of Pediatrics at the University of Montreal, Canada, and he is the Head of the Research Axis “Immune Diseases and Cancer” at CHU Sainte-Justine Research Center.

The major activity of his clinical research is focused on primary immune deficiency and as a recognized expert on this field.

The major activity of his fundamental research is on cancer immunotherapy, mostly on the field of NK-cell and stem-cell based cellular therapy. Dr Haddad has also set up a humanized mice platform to develop relevant and innovative preclinical models of cancer immunotherapy and study of immunopathology.


A New Mechanism of NK-cell Cytotoxicity Against Pre-B ALL Cells 2:00 pm

Discovering NK cells’ capacity to kill supposedly resistant pre-B ALL cells Outlining mechanisms that cause delayed killing independent of granule exocytosis or the death receptors cytotoxic pathways Discussing how this new mechanism does not require caspase activation or mitochondrial depolarizationRead more

day: Workshop

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.